Fluorouracil News and Research

RSS
Fluorouracil is a drug used to treat symptoms of cancer of the colon, breast, stomach, and pancreas. It is also used in a cream to treat certain skin conditions. Fluorouracil stops cells from making DNA and it may kill cancer cells. It is a type of antimetabolite. Also called 5-fluorouracil and 5-FU.
Study: Recurrence of SCCOP may differ in HPV-positive and HPV-negative patients

Study: Recurrence of SCCOP may differ in HPV-positive and HPV-negative patients

EORTC trial follow-up shows chemo-radiotherapy for patients with rectal cancer does not improve survival

EORTC trial follow-up shows chemo-radiotherapy for patients with rectal cancer does not improve survival

RoundTable Healthcare Partners sells Aqua Pharmaceuticals Holdings for $402.6M to Almirall

RoundTable Healthcare Partners sells Aqua Pharmaceuticals Holdings for $402.6M to Almirall

New drug combination therapy effective for patients with HER2-positive breast cancer

New drug combination therapy effective for patients with HER2-positive breast cancer

CTCA doctor presents cutting-edge treatments for cancer patients to medical colleagues

CTCA doctor presents cutting-edge treatments for cancer patients to medical colleagues

Aflibercept drug shows minor added benefit for overall survival in colorectal cancer patients

Aflibercept drug shows minor added benefit for overall survival in colorectal cancer patients

Report: 83% of cancer doctors face oncology drug shortages

Report: 83% of cancer doctors face oncology drug shortages

Combination of cetuximab and chemotherapy improves tumor shrinkage, extends survival

Combination of cetuximab and chemotherapy improves tumor shrinkage, extends survival

Tumor texture analysis has prognostic potential

Tumor texture analysis has prognostic potential

Regeneron fourth quarter total revenues increase to $415 million

Regeneron fourth quarter total revenues increase to $415 million

Oncolytics Biotech reports new findings at ASCO’s 2013 Gastrointestinal Cancers Symposium

Oncolytics Biotech reports new findings at ASCO’s 2013 Gastrointestinal Cancers Symposium

Genentech receives FDA approval for new use of Avastin plus chemotherapy to treat mCRC

Genentech receives FDA approval for new use of Avastin plus chemotherapy to treat mCRC

Oxaliplatin and bevacizumab disappoint for rectal cancer

Oxaliplatin and bevacizumab disappoint for rectal cancer

Combining 5-fluorouracil and IL-1 beta inhibitor can improve effectiveness of chemotherapy

Combining 5-fluorouracil and IL-1 beta inhibitor can improve effectiveness of chemotherapy

Bevacizumab ruled out for stage III colorectal cancer

Bevacizumab ruled out for stage III colorectal cancer

Taiho Pharmaceutical announces early stage data for eight novel oncology compounds

Taiho Pharmaceutical announces early stage data for eight novel oncology compounds

FoXTROT results: preoperative chemo could become new standard

FoXTROT results: preoperative chemo could become new standard

Nonclinical data on Provectus PV-10 oncology drug presented at 27th SITC

Nonclinical data on Provectus PV-10 oncology drug presented at 27th SITC

NewLink Genetics to launch algenpantucel-L Phase 3 study in pancreatic cancer

NewLink Genetics to launch algenpantucel-L Phase 3 study in pancreatic cancer

Bayer HealthCare receives FDA approval for Stivarga to treat colorectal cancer

Bayer HealthCare receives FDA approval for Stivarga to treat colorectal cancer